[1]陈 凯,姚 婧,杨 华,等.孟景春教授治疗COPD临床经验[J].陕西中医,2021,(2):235-238.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.025]
　CHEN Kai,YAO Jing,YANG Hua,et al.Professor Meng Jingchun's experience in treating chronic obstructive pulmonary disease[J].,2021,(2):235-238.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.025]
点击复制

孟景春教授治疗COPD临床经验
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年2期
页码:
235-238
栏目:
名中医经验
出版日期:
2021-02-05

文章信息/Info

Title:
Professor Meng Jingchun's experience in treating chronic obstructive pulmonary disease
作者:
陈 凯1; 姚 婧1; 杨 华1 ; 包永生2
(1.苏州市中西医结合医院肺病科,江苏 苏州 215101; 2.河南中医药大学,河南 郑州 450046)
Author(s):
CHEN Kai; YAO Jing; YANG Hua; BAO Yongsheng
(Department of Lung Diseases,Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,Suzhou 215101,China)
关键词:
慢性阻塞性肺疾病;  肺胀;  临床经验;  辨证;  急性期;  缓解期
Keywords:
Chronic obstructive pulmonary disease;  Pulmonary distension;  Clinical experience;  Syndrome differentiation;  Acute stage;  Remission stage
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2020.02.025
文献标志码:
A
摘要:
目的:分析孟景春教授治疗慢性阻塞性肺疾病(COPD)的临床经验。方法: 通过查阅大量孟景春教授治疗COPD的相关文献,进行分析整理,归纳总结孟景春教授的治疗经验及用药特色。结果:孟教授认为 COPD可归属中医学“肺胀”“痰饮”“喘证”等范畴,病因主要在于肺脾肾亏虚,复为邪所乘,痰浊、水饮、瘀血相互影响和转化使肺胀进一步加重。在治疗上强调辨证论治,重视分期辨证、整体辨证论治。COPD急性加重期是在肺肾气虚、气虚血瘀的基础上外感新邪而诱发,以清热、祛痰、平喘、化瘀为治则。待表证消散,热邪得清,病情趋于平稳,补肺健脾益肾,卫气固而邪难侵。在临床上取得了良好的疗效。结论:孟教授认为COPD为本虚标实之病,“急者治其标”,宣肺化痰,清解外邪,活血化瘀为治则,“缓则治其本”,补肺脾肾为治则。
Abstract:
Objective:To analysis the clinical experience of Professor Meng Jingchun in treating chronic obstructive pulmonary disease(COPD).Methods:This study analyzed and sorted out Professor Meng Jingchun's treatment experience and medication characteristics by reviewing a large number of relevant literature focusing on the treatment of COPD by Professor Meng Jingchun.Results:Professor Meng believes that COPD can be classified into the categories of “lung distension”“phlegm and retained fluid”and “syndrome characterized by dyspnea” in traditional Chinese medicine.The main cause of the disease is the deficiency of lung,spleen and kidney,and its recurrence may be associated with the attack of pathogenic factors.The mutual influence and transformation of phlegm turbidity,retained fluid and blood stasis may further aggravate lung distention.In the treatment,Professor Meng Jingchun emphasizes the differentiation of symptoms and signs,the differentiation of symptoms by stages,and the overall differentiation of symptoms and signs.The acute exacerbation stage of COPD is induced by external new pathogens on the basis of lung-kidney Qi deficiency,as well as Qi deficiency and blood stasis.The treatment options mainly consist of clearing away heat and eliminating phlegm,relieving asthma and removing blood stasis.When the exterior syndrome is dissipated and the pathogenic heat is cleared,the condition of COPD tends to be stable with the invigoration of lungs,the spleen and kidneys,resulting in the stablization of Qi and prevention of pathogen invasion.It has achieved good clinical effects in accordance with the therapeutic experience of Professor Meng Jingchun.Conclusion:Professor Meng believes that COPD is a disease with deficiency in origin and excess in superficislity.For “patients with acute onset of COPD”,it shall emphasize on alleviating the symptoms by ventilating the lung and resolving phlegm,clearing away external pathogenic factors,promoting blood circulation and removing blood stasis.Meanwhile,for “patients in the remission stage of COPD”,it shall focus on address the root cause by following the principle of tonifying lungs,the spleen and kidneys.

参考文献/References:

[1] 焦文妤,尚家璐,李树霞,等.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,48(12):1616-1621.
[2] 秦国双,温昊于,宇传华.中国 COPD 的患病发病及 YLD 现状及趋势[J].公共卫生与预防医学,2019,30(2):4-8.
[3] 刘娅钦,马 丽,刘 琳.慢性阻塞性肺疾病发病机制的研究进展[J].临床肺科杂志,2016,21(6):1113-1116.
[4] 景 璇,郭 洁,赵小静,等.慢性阻塞性肺疾病急性加重期的中医治疗研究进展[J].世界中医药,2016,11(7):1384-1388.
[5] 刘栋强,徐顺贵,林劲榕.慢性阻塞性肺疾病中医证候病机研究进展[J].光明中医,2018,33(22):3443-3445.
[6] 黄立搜,汪丙柱,李飞泽,等.宋康教授辨治慢性阻塞性肺疾病经验探析[J].浙江中医药大学学报,2017,41(10):810-812.
[7] 潘志鹏,魏成功,段晨霞,等.魏成功教授治疗慢性阻塞性肺疾病临床经验总结[J].中医临床研究,2020,12(1):64-66.
[8] 杨 霖,赵生敏,武正州.慢性阻塞性肺疾病急性期患者凝血功能变化[J].川北医学院学报,2017,32(2):227-229.
[9] 邓秀娟,黄 乐,谭宇军,等.胡学军从痰瘀论治晚期慢性阻塞性肺疾病经验[J].湖南中医杂志,2020,36(6):21-22.
[10] 张 念,袁文胜,殷人易,等.清热化痰活血降气法治疗老年热证慢性阻塞性肺疾病患者的疗效观察[J].重庆医学,2016,45(32):4563-4565.
[11] 马 敏,田 青.清热化痰理气方联合左氧氟沙星治疗慢性阻塞性肺疾病患者疗效及对免疫功能的影响[J].陕西中医,2016,37(7):834-835.
[12] 程建超,朱 洁,芮轶群,等.从“肺主治节"论治COPD肺血管重构[J].云南中医学院学报,2015,38(2):37-39.
[13] 陈远彬,吴 蕾,于旭华,等.培土生金”中医理论溯源及治疗慢性阻塞性肺疾病的古籍文献研究[J].辽宁中医杂志,2019,46(6):1193-1195.
[14] 魏晓静,王振伟,杨佩兰.培土生金法治疗慢性阻塞性肺病研究进展[J].山东中医杂志,2016,35(5):473-475.
[15] 李修元,彭素岚,唐 倩.气阳虚弱为慢性阻塞性肺疾病急性加重期的内因理论思考[J].中国中医急症,2017,26(11):1964-1966.
[16] 张亚达,姚 亮,王振伟,等.金水相生法治疗慢性阻塞性肺疾病稳定期肺肾两虚证研究进展[J].实用临床医药杂志,2019,23(8):119-122.
[17] 王晶波,秦 帅,韩 啸.从“金水相生”角度论治肺间质纤维化[J].辽宁中医药大学学报,2019,21(12):21-23.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(2):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(2):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(2):1491.
[5]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(2):57.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(2):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(2):534.
[9]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(2):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[10]赵丽萍,武慧强.宋一亭教授治疗肺心病临床经验[J].陕西中医,2020,(10):1471.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.037]
[11]文思敏,范玉琴,朱建平,等.名中医张震从虚、痰、瘀辨治慢性阻塞性肺疾病经验[J].陕西中医,2024,(4):532.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.022]
　WEN Simin,FAN Yuqin,ZHU Jianping,et al.Experience of famous traditional Chinese medicine Zhang Zhen differentiates and treats chronic obstructive pulmonary disease from deficiency,phlegm,and stasis[J].,2024,(2):532.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.022]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(81573881); 河南省科技攻关计划项目( 182102311163); 江苏省苏州市科技发展计划基金资助项目(SYSD2018204)
更新日期/Last Update: 2021-01-28